Expression of ATP/GTP Binding Protein 1 Has Prognostic Value for the Clinical Outcomes in Non-Small Cell Lung Carcinoma

被引:3
|
作者
Kwak, Hee Jeong [1 ]
Gil, Minchan [1 ]
Chae, Hee Sung [1 ]
Seok, Jaekwon [1 ]
Soundrarajan, Nagasundarapandian [1 ]
Saha, Subbroto Kumar [1 ]
Kim, Aram [2 ]
Park, Kyoung Sik [3 ]
Park, Chankyu [1 ]
Cho, Ssang-Goo [1 ]
机构
[1] Konkuk Univ, Incurable Dis Anim Model & Stem Cell Inst IDASI, Dept Stem Cell & Regenerat Biotechnol, 120 Neungdong Ro, Seoul 05029, South Korea
[2] Konkuk Univ, Med Ctr, Sch Med, Dept Urol, Seoul 05029, South Korea
[3] Konkuk Univ, Sch Med, Med Ctr, Dept Surg, Seoul 05029, South Korea
来源
JOURNAL OF PERSONALIZED MEDICINE | 2020年 / 10卷 / 04期
关键词
AGTPBP1; lung cancer; expression level; prognosis; patient survival; TUBULIN TYROSINE LIGASE; MICROTUBULE DYNAMICS; GENE-EXPRESSION; ALPHA-TUBULIN; BETA-TUBULIN; CANCER CELLS; WEB SERVER; DOXORUBICIN; APOPTOSIS; PATHWAY;
D O I
10.3390/jpm10040263
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
ATP/GTP binding protein 1 (AGTPBP1) encodes a crucial protein, cytosolic carboxypeptidase 1 (CCP1), which plays a role in modulating the polyglutamylation of tubulin and has been studied in degenerative diseases. However, the role of AGTPBP1 in malignancy has not been completely studied yet. In this study, we examined the role of AGTPBP1 in cancer progression, its association with patient survival, and related mechanisms in lung cancer, using the A549 cell line and lung cancer gene expression datasets. AGTPBP1 knockdown increased the proliferation, migration, sphere formation, and drug resistance of A549 cells. Lung cancer datasets revealed significantly lower mRNA and protein expression levels of AGTPBP1 in lung cancer tissues, as compared to those in normal tissues. Importantly, AGTPBP1 expression positively correlated with patient survival. Analysis of co-expressed genes revealed that AGTPBP1 expression positively correlated with immune infiltration in lung cancer. Our results conclusively suggested that AGTPBP1 expression was correlated with cancer progression and immune infiltration in lung cancer.
引用
收藏
页码:1 / 22
页数:22
相关论文
共 50 条
  • [1] Prognostic value of LIPC in non-small cell lung carcinoma
    Galluzzi, Lorenzo
    Goubar, Aicha
    Olaussen, Ken Andre
    Vitale, Ilio
    Senovilla, Laura
    Michels, Judith
    Robin, Angelique
    Dorvault, Nicolas
    Besse, Benjamin
    Validire, Pierre
    Fouret, Pierre
    Behrens, Carmen
    Wistuba, Ignacio Ivan
    Soria, Jean-Charles
    Kroemer, Guido
    CELL CYCLE, 2013, 12 (04) : 647 - 654
  • [2] Clinical significance and prognostic value of Vav1 expression in Non-small cell lung cancer
    Qi, Yao
    Kong, Fan-Ming
    Deng, Qi
    Li, Jing-Yi
    Cui, Rui
    Pu, Ye-Di
    Zhai, Qiong-Li
    Jia, Ying-Jie
    Li, Yu-Ming
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (08): : 2491 - 2497
  • [3] Overexpression of RhoE has a prognostic value in non-small cell lung cancer
    Zhang, Cuiyan
    Zhou, Fang
    Li, Ning
    Shi, Susheng
    Feng, Xiaoli
    Chen, Zhaoli
    Hang, Jie
    Qiu, Bin
    Li, Baozhong
    Chang, Sheng
    Wan, Junting
    Shao, Kang
    Xing, Xuezhong
    Tan, Xiaogang
    Wang, Zhen
    Xiong, Meihua
    He, Jie
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (09) : 2628 - 2635
  • [4] Prognostic value of aspartyl (asparaginyl)-β-hydroxylase/humbug expression in non-small cell lung carcinoma
    Luu, Martin
    Sabo, Edmond
    de la Monte, Suzanne M.
    Greaves, Wesley
    Wang, JiYi
    Tavares, Rosemarie
    Simao, Lelia
    Wands, Jack R.
    Resnick, Murray B.
    Wang, LiJuan
    HUMAN PATHOLOGY, 2009, 40 (05) : 639 - 644
  • [5] PROGNOSTIC VALUE OF THE PROTEIC EXPRESSION PROFILE IN LOCALLY ADVANCED NON-SMALL CELL LUNG CARCINOMA
    Morbeck, Igor P.
    Gross, Jefferson L.
    Andrade, Victor
    Fogaroli, Ricardo
    Haddad, Fabio
    Younes, Riad
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S949 - S949
  • [6] SPARC expression and prognostic value in non-small cell lung cancer
    Huang, Yan
    Zhang, Jing
    Zhao, Yuan-Yuan
    Jiang, Wei
    Xue, Cong
    Xu, Fei
    Zhao, Hong-Yun
    Zhang, Yang
    Zhao, Li-Ping
    Hu, Zhi-Huang
    Yao, Zhi-Wen
    Liu, Qian-Yong
    Zhang, Li
    CHINESE JOURNAL OF CANCER, 2012, 31 (11) : 541 - 548
  • [7] The clinical impact of PD-L1 protein expression in non-small cell lung carcinoma
    Yanagawa, N.
    Shiono, S.
    Ogata, S-Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Overexpression of Periostin Protein in Non-Small Cell Lung Carcinoma is Not Related with Clinical Prognostic Significance
    Park, Won Young
    Shin, Dong Hoon
    Kim, Jae Ho
    Lee, Min Ki
    Lee, Ho Seok
    Lee, Chang Hun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2012, 72 (02) : 132 - 139
  • [9] Prognostic value of DNA cytometry in patients with non-small cell lung carcinoma
    Skuballa, A
    Starke, U
    Achatzy, R
    Hutschenreiter, J
    6TH EUROPEAN CONFERENCE ON GENERAL THORACIC SURGERY, 1998, : 89 - 92
  • [10] Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma
    Seyhan, Ekrem Cengiz
    Altin, Sedat
    Cetinkaya, Erdogan
    Sokucu, Sinem
    Abali, Hulya
    Buyukpinarbasili, Nur
    Fener, Neslihan
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2010, 5 (05): : 305 - 311